Biotechnology How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 54% November 28, 2022
Biotechnology BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE November 28, 2022
Biotechnology FibroGen to Participate at Bank of America 2022 Biotech SMID Cap Virtual Conference November 28, 2022
Biotechnology Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation November 28, 2022
Health C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 million¹ with AstraZeneca for the development and commercialisation of NRF2 Activator programme November 28, 2022
Health Hoth Therapeutics Announces Its New Product, Ht-Alz Therapeutic, Gives Cognitive Improvements In Alzheimer’s Disease Model In Mouse July 26, 2022